We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

April 10, 2009

Federal Trade Commission et al v. Actavis, Inc.

View recent docket activity


Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.


Coverage

  1. February 28, 2019

    Original FTC V. Actavis Case Ends With AbbVie AndroGel Deal

    AbbVie Inc. has agreed not to enter settlements that illegally delay the entry of certain generic drugs, allowing it to avoid a related trial over its testosterone treatment AndroGel slated to start Monday and officially putting an end to the landmark Federal Trade Commission v. Actavis litigation, the agency said Thursday.

26 other articles on this case. View all »

Parties

To view the parties, register now.